{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T03:04:16Z","timestamp":1789268656373,"version":"build-2803163510"},"reference-count":344,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,12]],"date-time":"2014-03-12T00:00:00Z","timestamp":1394582400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0089566","type":"journal-article","created":{"date-parts":[[2014,3,12]],"date-time":"2014-03-12T20:25:04Z","timestamp":1394655904000},"page":"e89566","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":136,"title":["Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System"],"prefix":"10.1371","volume":"9","author":[{"given":"John M.","family":"McPartland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey W.","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Di Marzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,3,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","article-title":"Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain","volume":"77","author":"M Glass","year":"1997","journal-title":"Neuroscience"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/157015911795017416","article-title":"Commentary: functional neuronal CB2 cannabinoid receptors in the CNS","volume":"9","author":"ES Onaivi","year":"2011","journal-title":"Current Neuropharmacology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1476-5381.2010.00729.x","article-title":"CB2: a cannabinoid receptor with an identity crisis","volume":"160","author":"BK Atwood","year":"2010","journal-title":"British Journal of Pharmacology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11481-009-9177-z","article-title":"Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels","volume":"5","author":"L De Petrocellis","year":"2010","journal-title":"Journal of Neuroimmune Pharmacology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0005-2760(98)00042-3","article-title":"\u2018Endocannabinoids\u2019 and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance","volume":"1392","author":"V Di Marzo","year":"1998","journal-title":"Biochimica et Biophysica Acta - Lipids and Lipid Metabolism"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-3-642-17214-4_4","article-title":"Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes","author":"V Di Marzo","year":"2011","journal-title":"Handbook of Experimental Pharmacology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pbb.2010.03.012","article-title":"The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning","volume":"95","author":"FJ Bermudez-Silva","year":"2010","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"ref8","first-page":"31","article-title":"Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions","volume":"25","author":"EB Russo","year":"2004","journal-title":"Neuro Endocrinol Lett"},{"key":"ref9","first-page":"24","article-title":"The endocannabinoid-CB receptor system: Importance for development and in pediatric disease","volume":"25","author":"E Fride","year":"2004","journal-title":"Neuroendocrinology Letters"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00008877-200509000-00006","article-title":"Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression","volume":"16","author":"MN Hill","year":"2005","journal-title":"Behav Pharmacol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/sj.npp.1300558","article-title":"Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms","volume":"29","author":"A Giuffrida","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/sj.npp.1301246","article-title":"Endocannabinoids in chronic migraine: CSF findings suggest a system failure","volume":"32","author":"P Sarchielli","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/jnnp.2007.139071","article-title":"Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis","volume":"79","author":"M Di Filippo","year":"2008","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jchemneu.2009.02.001","article-title":"Cannabinoid (CB1), GABA<sub>A<\/sub> and GABA<sub>B<\/sub> receptor subunit changes in the globus pallidus in Huntington&apos;s disease","volume":"37","author":"KL Allen","year":"2009","journal-title":"Journal of Chemical Neuroanatomy"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2967\/jnumed.110.077156","article-title":"Widespread decrease of type 1 cannabinoid receptor availability in Huntington disease in vivo","volume":"51","author":"K Van Laere","year":"2010","journal-title":"Journal of Nuclear Medicine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/mds.23014","article-title":"Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson&apos;s disease patients","volume":"25","author":"V Pisani","year":"2010","journal-title":"Movement Disorders"},{"key":"ref17","article-title":"Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea","volume":"24","author":"BS Wong","year":"2012","journal-title":"Neurogastroenterology and Motility"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.biopsych.2011.05.010","article-title":"Brain type 1 cannabinoid receptor availability in patients with anorexia and bulimia nervosa","volume":"70","author":"N Gerard","year":"2011","journal-title":"Biological Psychiatry"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010752","article-title":"Motion sickness, stress and the endocannabinoid system","volume":"5","author":"A Chouker","year":"2010","journal-title":"PLoS ONE"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0140-6736(02)09812-4","article-title":"Systematic reviews of animal experiments","volume":"360","author":"P Sandercock","year":"2002","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/01.STR.0000125719.25853.20","article-title":"Pooling of animal experimental data reveals influence of study design and publication bias","volume":"35","author":"MR Macleod","year":"2004","journal-title":"Stroke"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/sj.bjp.0707399","article-title":"Meta-analysis of cannabinoid ligand binding affinity and cannabinoid receptor distribution: interspecies differences","volume":"152","author":"JM McPartland","year":"2007","journal-title":"British Journal of Pharmacology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.yjmcc.2011.04.008","article-title":"Preclinical studies of human disease: time to take methodological quality seriously","volume":"51","author":"HB van der Worp","year":"2011","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"A Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"ref25","first-page":"89","article-title":"Benign prostatic hyperplasia treated with saw palmetto: a literature search and an experimental case study","volume":"100","author":"JM McPartland","year":"2000","journal-title":"J Am Osteopath Assoc"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbr.2012.09.005","article-title":"Measuring behaviour in rodents: towards translational neuropsychiatric research","volume":"236","author":"JR Hornberg","year":"2013","journal-title":"Behavioural Brain Research"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1006\/abbi.1998.1025","article-title":"Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen","volume":"362","author":"CJ Fowler","year":"1999","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1021\/ja308733u","article-title":"A binding site for nonsteroidal anti-inflammatory drugs in fatty acid amide hydrolase","volume":"135","author":"L Bertolacci","year":"2013","journal-title":"Journal of the American Chemical Society"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"44877","DOI":"10.1074\/jbc.M206788200","article-title":"Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides","volume":"277","author":"KR Kozak","year":"2002","journal-title":"J Biol Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1113\/jphysiol.2006.105569","article-title":"PGE<sub>2<\/sub> glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons","volume":"572","author":"N Sang","year":"2006","journal-title":"Journal of Physiology-London"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/bjp.2008.33","article-title":"Prostaglandin E-2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NF kappa B activity","volume":"153","author":"SSJ Hu","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"ref32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031111","article-title":"Discovery of prostamide F-2 alpha and its role in inflammatory pain and dorsal horn nociceptive neuron hyperexcitability","volume":"7","author":"L Gatta","year":"2012","journal-title":"Plos One"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nn1262","article-title":"Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus","volume":"7","author":"J Kim","year":"2004","journal-title":"Nature Neuroscience"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0014-2999(02)02485-8","article-title":"A role for endocannabinoids in indomethacin-induced spinal antinociception","volume":"454","author":"H G\u00fchring","year":"2002","journal-title":"European Journal of Pharmacology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1046\/j.1460-9568.2003.02470.x","article-title":"Intrathecally applied flurbiprofen produces an endocannabinoid-dependent antinociception in the rat formalin test","volume":"17","author":"M Ates","year":"2003","journal-title":"European Journal of Neuroscience"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pain.2007.01.015","article-title":"Blockade of central cyclooxygenase (COX) pathways enhances the cannabinoid-induced antinociceptive effects on inflammatory temporomandibular joint (TMJ) nociception","volume":"132","author":"DK Ahn","year":"2007","journal-title":"Pain"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/187152709789824660","article-title":"The endocannabinoid system and pain","volume":"8","author":"J Guindon","year":"2009","journal-title":"CNS & Neurological Disorders-Drug Targets"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.phrs.2012.02.012","article-title":"Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions","volume":"65","author":"O Sasso","year":"2012","journal-title":"Pharmacological Research"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000055673","article-title":"Interaction between Delta-9-tetrahydrocannabinol and indomethacin","volume":"33","author":"K Green","year":"2001","journal-title":"Ophthalmic Research"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0024-3205(91)90465-N","article-title":"Antagonism of marihuana effects by indomethacin in humans","volume":"48","author":"M Perez Reyes","year":"1991","journal-title":"Life Sciences"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00006565-200002000-00012","article-title":"Central nervous system manifestations of an ibuprofen overdose reversed by naloxone","volume":"16","author":"RB Easley","year":"2000","journal-title":"Pediatr Emerg Care"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1369-1600.2008.00126.x","article-title":"Cannabimimetic effects modulated by cholinergic compounds","volume":"13","author":"JM McPartland","year":"2008","journal-title":"Addiction Biology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"31405","DOI":"10.1074\/jbc.M501489200","article-title":"Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system","volume":"280","author":"ED H\u00f6gest\u00e4tt","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejphar.2007.07.012","article-title":"The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors","volume":"573","author":"M Dania","year":"2007","journal-title":"European Journal of Pharmacology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejphar.2005.12.015","article-title":"The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors","volume":"531","author":"A Ottani","year":"2006","journal-title":"European Journal of Pharmacology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pain.2008.03.030","article-title":"Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia","volume":"139","author":"C Mallet","year":"2008","journal-title":"Pain"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.pnpbp.2009.06.020","article-title":"Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors","volume":"33","author":"SN Umathe","year":"2009","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/ncomms1559","article-title":"TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid D<sup>9<\/sup>-tetrahydrocannabiorcol","volume":"2","author":"DA Andersson","year":"2011","journal-title":"Nature Communications"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pnpbp.2012.04.011","article-title":"Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice","volume":"38","author":"GG Gould","year":"2012","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pain.2006.12.019","article-title":"Central glucocorticoid receptors regulate the upregulation of spinal cannabinoid-1 receptors after peripheral nerve injury in rats","volume":"131","author":"S Wang","year":"2007","journal-title":"Pain"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.bone.2011.08.022","article-title":"Cannabinoid receptor 1 regulates ERK and GSK-3 beta-dependent glucocorticoid inhibition of osteoblast differentiation in murine MC3T3-E1 cells","volume":"49","author":"RW Wu","year":"2011","journal-title":"Bone"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/art.33457","article-title":"Cannabinoid receptor 1 mediates glucocorticoid-induced bone loss in rats by perturbing bone mineral acquisition and marrow adipogenesis","volume":"64","author":"JY Ko","year":"2012","journal-title":"Arthritis and Rheumatism"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1523\/JNEUROSCI.23-12-04850.2003","article-title":"Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism","volume":"23","author":"S Di","year":"2003","journal-title":"Journal of Neuroscience"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1210\/en.2005-0610","article-title":"Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and gamma-aminobutyric acid inputs to hypothalamic magnocellular neurons","volume":"146","author":"S Di","year":"2005","journal-title":"Endocrinology"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.1523\/JNEUROSCI.5126-05.2006","article-title":"Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release","volume":"26","author":"R Malcher-Lopes","year":"2006","journal-title":"Journal of Neuroscience"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1113\/jphysiol.2012.238659","article-title":"Endocannabinoids mediate the glucocorticoid-induced inhibition of excitatory synaptic transmission to dorsal raphe serotonin neurons","volume":"590","author":"J Wang","year":"2012","journal-title":"Journal of Physiology-London"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.psyneuen.2010.03.005","article-title":"Rapid elevations in limbic endocannabinoid content by glucocorticoid hormones in vivo","volume":"35","author":"MN Hill","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"10506","DOI":"10.1523\/JNEUROSCI.0496-11.2011","article-title":"Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response","volume":"31","author":"MN Hill","year":"2011","journal-title":"Journal of Neuroscience"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/hipo.20386","article-title":"Prolonged glucocorticoid treatment decreases cannabinoid CB<sub>1<\/sub> receptor density in the hippocampus","volume":"18","author":"MN Hill","year":"2008","journal-title":"Hippocampus"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1073\/pnas.1200742109","article-title":"Glucocorticoids interact with the hippocampal endocannabinoid system in impairing retrieval of contextual fear memory","volume":"109","author":"P Atsak","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuroscience.2011.08.048","article-title":"Chronic, noninvasive glucocorticoid administration suppresses limbic endocannabinoid signaling in mice","volume":"204","author":"NP Bowles","year":"2012","journal-title":"Neuroscience"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/gut.2008.157594","article-title":"Reciprocal changes in vanilloid (TRPV1) and endocannabinoid (CB1) receptors contribute to visceral hyperalgesia in the water avoidance stressed rat","volume":"58","author":"S Hong","year":"2009","journal-title":"Gut"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0028-3908(02)00364-7","article-title":"Regional differences in naloxone modulation of \u0394<sup>9<\/sup>-THC induced Fos expression in rat brain","volume":"44","author":"KV Allen","year":"2003","journal-title":"Neuropharmacology"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0022-3565(24)29518-5","article-title":"Changes in opioid and cannabinoid receptor protein following short-term combination treatment with \u0394<sup>9<\/sup>- tetrahydrocannabinol and morphine","volume":"297","author":"DL Cichewicz","year":"2001","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/j.1460-9568.2007.05470.x","article-title":"Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2","volume":"25","author":"L Fattore","year":"2007","journal-title":"European Journal of Neuroscience"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.neuropharm.2006.05.019","article-title":"Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core","volume":"51","author":"ANM Schoffelmeer","year":"2006","journal-title":"Neuropharmacology"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/j.1460-9568.2004.03645.x","article-title":"Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine","volume":"20","author":"D Vigan\u00f2","year":"2004","journal-title":"European Journal of Neuroscience"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0376-8716(01)00186-7","article-title":"Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB1 receptor binding and mRNA levels","volume":"66","author":"S Gonzalez","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.cellsig.2009.12.003","article-title":"Agonist-dependent mu-opioid receptor signaling can lead to heterologous desensitization","volume":"22","author":"J Chu","year":"2010","journal-title":"Cellular Signalling"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1046\/j.1460-9568.2003.02951.x","article-title":"Cannabinoid receptor and WIN 55 212-2-stimulated [35S]-GTPgammaS binding in the brain of mu-, delta- and kappa-opioid receptor knockout mice","volume":"18","author":"F Berrendero","year":"2003","journal-title":"Eur J Neurosci"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.bbamcr.2009.05.002","article-title":"Cannabinoid CB1 receptor elevation of intracellular calcium in neuroblastoma SH-SY5Y cells: interactions with muscarinic and delta-opioid receptors","volume":"1793","author":"P Marini","year":"2009","journal-title":"Biochimica Et Biophysica Acta-Molecular Cell Research"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/sj.bjp.0705932","article-title":"CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat","volume":"143","author":"MS Spano","year":"2004","journal-title":"British Journal of Pharmacology"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1038\/npp.2008.21","article-title":"Blockade of THC-seeking behavior and relapse in monkeys by the cannabinoid CB1-receptor antagonist rimonabant","volume":"33","author":"Z Justinova","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2004.10.043","article-title":"\u0394<sup>9<\/sup>-Tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats","volume":"506","author":"D Braida","year":"2004","journal-title":"European Journal of Pharmacology"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1111\/j.0953-816X.2004.03420.x","article-title":"beta-Endorphin elevations in the ventral tegmental area regulate the discriminative effects of delta-9-tetrahydrocannabinol","volume":"19","author":"M Solinas","year":"2004","journal-title":"European Journal of Neuroscience"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0022-3565(25)10720-9","article-title":"Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice","volume":"262","author":"SP Welch","year":"1992","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0022-3565(25)21168-5","article-title":"The role of endogenous opioids in enhancing the antinociception produced by the combination of delta-9-tetrahydrocannabinol and morphine in the spinal cord","volume":"279","author":"G Pugh","year":"1996","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0022-3565(24)38212-6","article-title":"Enhancement of \u03bc opioid antinociception by oral \u0394<sup>9<\/sup>-tetrahydrocannabinol: dose-response analysis and receptor identification","volume":"289","author":"DL Cichewicz","year":"1999","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2007.04.010","article-title":"Synergy between \u0394<sup>9<\/sup>-tetrahydrocannabinol and morphine in the arthritic rat","volume":"567","author":"ML Cox","year":"2007","journal-title":"European Journal of Pharmacology"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0014-2999(96)00752-2","article-title":"Potentiation of \u0394<sup>9<\/sup>-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of \u03bc- and \u03ba-opioid receptors","volume":"318","author":"I Reche","year":"1996","journal-title":"European Journal of Pharmacology"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02322290","article-title":"Die quantitative Problem der Pharmakologie","volume":"27","author":"WS Loewe","year":"1928","journal-title":"Ergebnisse der Physiologie"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/jps.3030290404","article-title":"Synergism of cannabis and butyl-bromathyl-barbituric acid","volume":"29","author":"WS Loewe","year":"1940","journal-title":"Journal of the American Pharmaceutical Association (Scientific edition)"},{"key":"ref83","unstructured":"Loewe WS (1944) Studies on the pharmacology of marihuana. In: Committee L, editor. The Marihuana Problem in the City of New York. Lancaster, PA: Jaques Cattell Press. pp. 149\u2013212."},{"key":"ref84","first-page":"72","article-title":"The action of chemical components of cannabis extracts","volume":"72","author":"WS Loewe","year":"1941","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1126\/science.102.2659.615","article-title":"Marihuana activity of cannabinol","volume":"102","author":"WS Loewe","year":"1945","journal-title":"Science"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2005.11.036","article-title":"Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine","volume":"530","author":"JD Roberts","year":"2006","journal-title":"European Journal of Pharmacology"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00213-002-1144-9","article-title":"Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol","volume":"163","author":"F Berrendero","year":"2002","journal-title":"Psychopharmacology"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0028-3908(98)00005-7","article-title":"Inhibition of opioid-degrading enzymes potentiates \u0394<sup>9<\/sup>-tetrahydrocannabinol-induced antinociception in mice","volume":"37","author":"I Reche","year":"1998","journal-title":"Neuropharmacology"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00213-002-1279-8","article-title":"Interaction between naltrexone and oral THC in heavy marijuana smokers","volume":"166","author":"M Haney","year":"2003","journal-title":"Psychopharmacology"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00213-010-1875-y","article-title":"Opioid antagonism enhances marijuana&apos;s effects in heavy marijuana smokers","volume":"211","author":"ZD Cooper","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.bjp.0701980","article-title":"Modulation of \u0394<sup>9<\/sup>-tetrahydrocannabinol-induced hypothermia by fluoxetine in the rat","volume":"124","author":"DT Malone","year":"1998","journal-title":"British Journal of Pharmacology"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000317059","article-title":"Behavioural effects of co-administration of delta 9-tetrahydrocannabinol with fluoxetine in rats","volume":"86","author":"M Goddard","year":"2010","journal-title":"Pharmacology"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s00702-008-0131-7","article-title":"Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents","volume":"115","author":"MN Hill","year":"2008","journal-title":"Journal of Neural Transmission"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1471-4159.2009.05898.x","article-title":"Altered CB1 receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine","volume":"108","author":"A Rodriguez-Gaztelumendi","year":"2009","journal-title":"Journal of Neurochemistry"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00213-007-1033-3","article-title":"Effects of chronic treatment with citalopram on cannabinoid and opioid receptor-mediated G-protein coupling in discrete rat brain regions","volume":"198","author":"SA Hesketh","year":"2008","journal-title":"Psychopharmacology"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1038\/npp.2010.99","article-title":"Deficiency in endocannabinoid signaling in the nucleus accumbens induced by chronic unpredictable stress","volume":"35","author":"W Wang","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1124\/mol.109.060079","article-title":"Long-term fluoxetine treatment modulates cannabinoid type 1 receptor-mediated inhibition of adenylyl cyclase in the rat prefrontal cortex through 5-hydroxytryptamine<sub>1A<\/sub> receptor-dependent mechanisms","volume":"77","author":"S Mato","year":"2010","journal-title":"Molecular Pharmacology"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1038\/sj.npp.1301092","article-title":"Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic-pituitary-adrenal axis","volume":"31","author":"MN Hill","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1111\/j.1471-4159.2008.05567.x","article-title":"Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment","volume":"106","author":"MN Hill","year":"2008","journal-title":"Journal of Neurochemistry"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejphar.2006.10.028","article-title":"Antidepressant-induced undesirable weight gain: prevention with rimonabant without interference with behavioral effectiveness","volume":"554","author":"N Gobshtis","year":"2007","journal-title":"European Journal of Pharmacology"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1471-4159.2007.04688.x","article-title":"Electroconvulsive shock treatment differentially modulates cortical and subcortical endocannabinoid activity","volume":"103","author":"MN Hill","year":"2007","journal-title":"Journal of Neurochemistry"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0028-3908(87)90213-9","article-title":"Enhancement of the hypothermic response of mice to delta-9-tetrahydrocannabinol by subhypothermic doses of chlorpromazine and phentolamine","volume":"23","author":"GA Gray","year":"1987","journal-title":"Neuropharmacology"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/jnr.20630","article-title":"Subchronic haloperidol increases CB(1) receptor binding and G protein coupling in discrete regions of the basal ganglia","volume":"82","author":"M Andersson","year":"2005","journal-title":"J Neurosci Res"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00210-005-1074-2","article-title":"Clozapine decreases [3H] CP 55940 binding to the cannabinoid 1 receptor in the rat nucleus accumbens","volume":"371","author":"S Sundram","year":"2005","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00213-012-2661-9","article-title":"Interactions between dopamine transporter and cannabinoid receptor ligands in rhesus monkeys","volume":"222","author":"DR Schulze","year":"2012","journal-title":"Psychopharmacology"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000245220","article-title":"Risperidone treatment increases CB1 receptor binding in rat brain","volume":"91","author":"A Secher","year":"2010","journal-title":"Neuroendocrinology"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1017\/S1461145707008048","article-title":"Chronic treatment with aripiprazole induces differential gene expression in the rat frontal cortex","volume":"11","author":"MC Cheng","year":"2008","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.brainres.2011.01.069","article-title":"Clozapine and SCH 23390 prevent the spatial working memory disruption induced by Delta(9)-THC administration into the medial prefrontal cortex","volume":"1382","author":"LCD Rodrigues","year":"2011","journal-title":"Brain Research"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00213-007-1042-2","article-title":"Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of delta-9-tetrahydrocannabinol in humans","volume":"198","author":"DC D'Souza","year":"2008","journal-title":"Psychopharmacology"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1177\/0269881109358200","article-title":"Central nervous system effects of haloperidol on THC in healthy male volunteers","volume":"24","author":"M Liem-Moolenaar","year":"2010","journal-title":"Journal of Psychopharmacology"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1177\/0269881112446534","article-title":"Does olanzapine inhibit the psychomimetic effects of \u0394<sup>9<\/sup>-tetrahydrocannabinol","volume":"26","author":"D Kleinloog","year":"2012","journal-title":"Journal of Psychopharmacology"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pbb.2007.11.001","article-title":"Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice","volume":"89","author":"N Naderi","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nbd.2009.06.015","article-title":"Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: possible involvement of the endocannabinoid and endovanilloid systems","volume":"36","author":"V Micale","year":"2009","journal-title":"Neurobiology of Disease"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1177\/0269881109106910","article-title":"The cannabinoid CB1 receptor is involved in the anxiolytic, sedative and amnesic actions of benzodiazepines","volume":"24","author":"MS Garcia-Gutierrez","year":"2010","journal-title":"Journal of Psychopharmacology"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.neuropharm.2004.01.003","article-title":"Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors","volume":"46","author":"L Urig\u00fcen","year":"2004","journal-title":"Neuropharmacology"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/npp.2008.98","article-title":"Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels","volume":"34","author":"V Micale","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/0028-3908(88)90029-9","article-title":"Drugs that stimulate or facilitate central GABAergic transmission interact synergistically with delta-9-tetrahydrocannabinol-induced to produce marked catalepsy in mice","volume":"27","author":"RG Pertwee","year":"1988","journal-title":"Neuropharmacology"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00426599","article-title":"Propranolol effects on acute marihuana intoxication in man","volume":"23","author":"A Sulkowski","year":"1977","journal-title":"Psychopharmacology (Berl)"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bja\/aeq117","article-title":"Effect of anaesthesia and cardiopulmonary bypass on blood endocannabinoid concentrations during cardiac surgery","volume":"105","author":"F Weis","year":"2010","journal-title":"British Journal of Anaesthesia"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0091-3057(77)90168-X","article-title":"Interactions between delta9-tetrahydrocannabinol and phencyclidine hydrochloride in rats","volume":"6","author":"GT Pryor","year":"1977","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"ref121","first-page":"39","article-title":"Medical marijuana and its use by the immunocompromised","volume":"3","author":"JM McPartland","year":"1997","journal-title":"Altern Ther Health Med"},{"key":"ref122","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/bja\/55.10.997","article-title":"Analgesic interaction between nitrous oxide and delta-9-tetrahydrocannabinol in the rat","volume":"55","author":"GP Novelli","year":"1983","journal-title":"British Journal of Anaesthesia"},{"key":"ref123","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00702-008-0076-x","article-title":"Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice","volume":"115","author":"N Naderi","year":"2008","journal-title":"Journal of Neural Transmission"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.neuropharm.2008.02.018","article-title":"An in vivo [18F]MK-9470 microPET study of type 1 cannabinoid receptor binding in Wistar rats after chronic administration of valproate and levetiracetam","volume":"54","author":"K Goffin","year":"2008","journal-title":"Neuropharmacology"},{"key":"ref125","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0091-3057(91)90366-A","article-title":"An investigation of the involvement of GABA in certain pharmacological effects of delta-9-tetrahydrocannabinol","volume":"40","author":"RG Pertwee","year":"1991","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.drugalcdep.2011.09.010","article-title":"Separate and combined effects of the GABA reuptake inhibitor tiagabine and \u0394<sup>9<\/sup>-THC in humans discriminating \u0394<sup>9<\/sup>-THC","volume":"122","author":"JA Lile","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S1734-1140(12)70867-8","article-title":"Synergistic interaction of pregabalin with the synthetic cannabinoid WIN 55,212-2 mesylate in the hot-plate test in mice: an isobolographic analysis","volume":"64","author":"JJ Luszczki","year":"2012","journal-title":"Pharmacological Reports"},{"key":"ref128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044813","article-title":"Vagus nerve stimulation reduces body weight and fat mass in rats","volume":"7","author":"S Banni","year":"2012","journal-title":"Plos One"},{"key":"ref129","doi-asserted-by":"crossref","first-page":"G63","DOI":"10.1152\/ajpgi.00059.2010","article-title":"Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype","volume":"299","author":"G Burdyga","year":"2010","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology"},{"key":"ref130","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jada.2008.12.022","article-title":"A systemic review of the roles of n-3 fatty acids in health and disease","volume":"109","author":"ND Riediger","year":"2009","journal-title":"Journal of the American Dietetic Association"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1038\/oby.2012.38","article-title":"Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity","volume":"20","author":"AR Alvheim","year":"2012","journal-title":"Obesity"},{"key":"ref132","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jnutbio.2011.05.005","article-title":"Hind limb suspension and long-chain omega-3 PUFA increase mRNA endocannabinoid system levels in skeletal muscle","volume":"23","author":"HL Hutchins-Wiese","year":"2012","journal-title":"Journal of Nutritional Biochemistry"},{"key":"ref133","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1194\/jlr.M002436","article-title":"Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma","volume":"51","author":"JT Wood","year":"2010","journal-title":"Journal of Lipid Research"},{"key":"ref134","doi-asserted-by":"crossref","DOI":"10.1186\/1743-7075-8-51","article-title":"Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice","volume":"8","author":"F Piscitelli","year":"2011","journal-title":"Nutrition & Metabolism"},{"key":"ref135","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nn.2736","article-title":"Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions","volume":"14","author":"M Lafourcade","year":"2011","journal-title":"Nature Neuroscience"},{"key":"ref136","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s13105-012-0179-6","article-title":"Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor signaling pathway in the brain and associated anxiety-like behavior in mice","volume":"68","author":"T Larrieu","year":"2012","journal-title":"Journal of Physiology and Biochemistry"},{"key":"ref137","doi-asserted-by":"crossref","first-page":"7647","DOI":"10.1073\/pnas.101119098","article-title":"Anandamide and diet: Inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets (vol 98, pg 6402, 2001)","volume":"98","author":"A Berger","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref138","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1006\/abbi.1999.1410","article-title":"Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina","volume":"370","author":"T Bisogno","year":"1999","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"ref139","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/carcin\/bgq151","article-title":"Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines","volume":"31","author":"I Brown","year":"2010","journal-title":"Carcinogenesis"},{"key":"ref140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.plefa.2012.08.002","article-title":"Synaptamide, endocannabinoid-like derivative of docosahexaenoic acid with cannabinoid-independent function","volume":"88","author":"HY Kim","year":"2013","journal-title":"Prostaglandins Leukotrienes and Essential Fatty Acids"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1476-511X-10-145","article-title":"Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations\u2013a comparative bioavailability study of fish oil vs. krill oil","volume":"10","author":"JP Schuchardt","year":"2011","journal-title":"Lipids Health Dis"},{"key":"ref142","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3945\/jn.109.104844","article-title":"Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats","volume":"139","author":"B Batetta","year":"2009","journal-title":"Journal of Nutrition"},{"key":"ref143","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.idairyj.2009.11.015","article-title":"Dietary krill oil increases docosahexaenoic acid and reduces 2-arachidonoylglycerol but not N-acylethanolamine levels in the brain of obese Zucker rats","volume":"20","author":"V Di Marzo","year":"2010","journal-title":"International Dairy Journal"},{"key":"ref144","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1743-7075-8-7","article-title":"Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects","volume":"8","author":"S Banni","year":"2011","journal-title":"Nutr Metab (Lond)"},{"key":"ref145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nm1521","article-title":"Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors","volume":"13","author":"C Rousseaux","year":"2007","journal-title":"Nat Med"},{"key":"ref146","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ygcen.2011.02.009","article-title":"Modulation of cortisol levels, endocannabinoid receptor 1A, proopiomelanocortin and thyroid hormone receptor alpha mRNA expressions by probiotics during sole (Solea solea) larval development","volume":"171","author":"FA Palermo","year":"2011","journal-title":"General and Comparative Endocrinology"},{"key":"ref147","doi-asserted-by":"crossref","DOI":"10.1038\/msb.2010.46","article-title":"The endocannabinoid system links gut microbiota to adipogenesis","volume":"6","author":"GG Muccioli","year":"2010","journal-title":"Molecular Systems Biology"},{"key":"ref148","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.freeradbiomed.2011.07.012","article-title":"alpha-tocopherol and alpha-tocopheryl phosphate interact with the cannabinoid system in the rodent hippocampus","volume":"51","author":"N Crouzin","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"ref149","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/25267","article-title":"Trick or treat from food endocannabinoids","volume":"396","author":"V Di Marzo","year":"1998","journal-title":"Nature"},{"key":"ref150","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000061850","article-title":"Lipids in neural function: modulation of behavior by oral administration of endocannabinoids found in foods","author":"G Crozier Willi","year":"2001","journal-title":"Nestle Nutr Workshop Ser Clin Perform Programme"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0014-2999(01)00953-0","article-title":"Critical role of the endogenous cannabinoid system in mouse pup suckling and growth","volume":"419","author":"E Fride","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"ref152","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/toxsci\/kfr081","article-title":"Effect of developmental chlorpyrifos exposure, on endocannabinoid metabolizing enzymes, in the brain of juvenile rats","volume":"122","author":"RL Carr","year":"2011","journal-title":"Toxicological Sciences"},{"key":"ref153","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1006\/taap.2001.9175","article-title":"Fatty acid amide hydrolase inhibition by neurotoxic organophosphorus pesticides","volume":"173","author":"CB Quistad","year":"2001","journal-title":"Toxicology and Applied Pharmacology"},{"key":"ref154","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2010.11.033","article-title":"The actions of benzophenanthridine alkaloids, piperonyl butoxide and (S)-methoprene at the G-protein coupled cannabinoid CB1 receptor in vitro","volume":"654","author":"AS Dhopeshwarkar","year":"2011","journal-title":"European Journal of Pharmacology"},{"key":"ref155","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.neuint.2011.06.019","article-title":"The G protein-coupled cannabinoid-1 (CB<sub>1<\/sub>) receptor of mammalian brain: inhibition by phthalate esters in vitro","volume":"59","author":"KM Bisset","year":"2011","journal-title":"Neurochemistry International"},{"key":"ref156","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.pain.2011.04.005","article-title":"Activation of cannabinoid receptors by the pentacyclic triterpene alpha,beta-amyrin inhibits inflammatory and neuropathic persistent pain in mice","volume":"152","author":"KAB Simao da Silva","year":"2011","journal-title":"Pain"},{"key":"ref157","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0091-3057(98)00195-6","article-title":"Thujone exhibits low affinity for cannabinoid receptors but fails to evoke cannabimimetic responses","volume":"62","author":"JP Meschler","year":"1999","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"ref158","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.chembiol.2009.09.012","article-title":"Discovery of potent and reversible monoacylglycerol lipase inhibitors","volume":"16","author":"AR King","year":"2009","journal-title":"Chem Biol"},{"key":"ref159","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/bjp.2008.294","article-title":"Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB1 receptors","volume":"155","author":"R Capasso","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"ref160","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/ibd.21873","article-title":"Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors","volume":"18","author":"J Fichna","year":"2012","journal-title":"Inflammatory Bowel Diseases"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1476-5381.2010.00716.x","article-title":"Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase","volume":"160","author":"L Thors","year":"2010","journal-title":"British Journal of Pharmacology"},{"key":"ref162","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1089\/jmf.2008.0243","article-title":"An examination of anthocyanins&apos; and anthocyanidins&apos; affinity for cannabinoid receptors","volume":"12","author":"G Korte","year":"2009","journal-title":"Journal of Medicinal Food"},{"key":"ref163","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.phymed.2009.10.001","article-title":"Tea catechins&apos; affinity for human cannabinoid receptors","volume":"17","author":"G Korte","year":"2010","journal-title":"Phytomedicine"},{"key":"ref164","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.phrs.2012.04.003","article-title":"Kavalactones and the endocannabinoid system: the plant-derived yangonin is a novel CB1 receptor ligand","volume":"66","author":"A Ligresti","year":"2012","journal-title":"Pharmacological Research"},{"key":"ref165","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1007\/s11064-012-0716-2","article-title":"The CB1 receptor-mediated endocannabinoid signaling and NGF: the novel targets of curcumin","volume":"37","author":"P Hassanzadeh","year":"2012","journal-title":"Neurochemical Research"},{"key":"ref166","first-page":"1147","article-title":"The dietary polyphenols trans-resveratrol and curcumin selectively bind human CB1 cannabinoid receptors with nanomolar affinities and function as antagonists\/inverse agonists (vol 330, pg 31, 2009)","volume":"331","author":"PL Prather","year":"2009","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref167","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0031-9422(03)00201-2","article-title":"Three isoflavanones with cannabinoid-like moieties from Desmodium canum","volume":"64","author":"B Botta","year":"2003","journal-title":"Phytochemistry"},{"key":"ref168","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1021\/np0102861","article-title":"Antimalarial (+)-trans-hexahydrodibenzopyran derivatives from Machaerium multiflorum","volume":"64","author":"I Muhammad","year":"2001","journal-title":"Journal of Natural Products"},{"key":"ref169","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/0031-9422(79)83025-3","article-title":"Cannabigerol-\u00e4hnliche verbendungen aus <italic>Helichrysum umbraculigerum<\/italic>","volume":"18","author":"F Bohlmann","year":"1979","journal-title":"Phytochemistry"},{"key":"ref170","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1248\/cpb.59.1409","article-title":"New cannabinoid-like chromane and chromene derivatives from Rhododendron anthopogonoides","volume":"59","author":"N Iwata","year":"2011","journal-title":"Chemical & Pharmaceutical Bulletin"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1248\/cpb.54.1046","article-title":"Chemical constituents of malagasy liverworts, Part V: Prenyl bibenzyls and clerodane diterpenoids with nitric oxide inhibitory activity from Radula appressa and Thysananthus spathulistipus","volume":"54","author":"L Harinantenaina","year":"2006","journal-title":"Chemical & Pharmaceutical Bulletin"},{"key":"ref172","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1248\/cpb.50.1390","article-title":"New bibenzyl cannabinoid from the New Zealand liverwort Radula marginata","volume":"50","author":"M Toyota","year":"2002","journal-title":"Chemical & Pharmaceutical Bulletin"},{"key":"ref173","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1021\/np200147c","article-title":"Benzyl derivatives with in vitro binding affinity for human opioid and cannabinoid receptors from the fungus Eurotium repens","volume":"74","author":"JT Gao","year":"2011","journal-title":"Journal of Natural Products"},{"key":"ref174","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1515\/znc-2001-11-1213","article-title":"Two novel phenylacetoxylated p-terphenyls from Thelephora ganbajun Zang","volume":"56","author":"H Lin","year":"2001","journal-title":"Z Naturforsch C"},{"key":"ref175","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0031-9422(94)85016-X","article-title":"Cannabiorci- and 8-chlorocannabiorcichromenic acid as fungal antagonists from Cylindrocarpon olidum","volume":"37","author":"K Quaghebeur","year":"1994","journal-title":"Phytochemistry"},{"key":"ref176","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.bcp.2010.02.015","article-title":"Falcarinol is a covalent cannabinoid CB1 receptor antagonist and induces pro-allergic effects in skin","volume":"79","author":"M Leonti","year":"2010","journal-title":"Biochemical Pharmacology"},{"key":"ref177","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1042\/bst0280654","article-title":"Cloning and functional expression of the first plant fatty acid elongase specific for Delta(6)-polyunsaturated fatty acids","volume":"28","author":"TK Zank","year":"2000","journal-title":"Biochemical Society Transactions"},{"key":"ref178","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/382677a0","article-title":"Brain cannabinoids in chocolate","volume":"382","author":"E di Tomaso","year":"1996","journal-title":"Nature"},{"key":"ref179","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1248\/bpb.23.758","article-title":"Occurrence of a novel cannabimimetic molecule 2- sciadonoylglycerol (2-eicosa-5\u2032, 11\u2032, 14\u2032-trienoylglycerol) in the umbrella pine Sciadopitys verticillata seeds","volume":"23","author":"S Nakane","year":"2000","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"ref180","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1021\/np200610t","article-title":"Cannabinomimetic lipid from a marine cyanobacterium","volume":"74","author":"M Gutierrez","year":"2011","journal-title":"Journal of Natural Products"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1021\/np970576a","article-title":"Grenadadiene and grenadamide, cyclopropyl-containing fatty acid metabolites from the marine cyanobacterium Lyngbya majuscula","volume":"61","author":"N Sitachitta","year":"1998","journal-title":"J Nat Prod"},{"key":"ref182","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-4899-1810-9_14","article-title":"Discovery of novel cannabinoid receptor ligands from diverse marine organisms","volume":"433","author":"K Soderstrom","year":"1997","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"ref183","doi-asserted-by":"crossref","first-page":"14192","DOI":"10.1074\/jbc.M601074200","article-title":"Alkylamides from Echinacea are a new class of cannabinomimetics - cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects","volume":"281","author":"S Raduner","year":"2006","journal-title":"Journal of Biological Chemistry"},{"key":"ref184","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.intimp.2009.03.006","article-title":"Synergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extracts","volume":"9","author":"A Chicca","year":"2009","journal-title":"International Immunopharmacology"},{"key":"ref185","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.phytochem.2011.06.008","article-title":"Alkamides and a neolignan from Echinacea purpurea roots and the interaction of alkamides with G-protein-coupled cannabinoid receptors","volume":"72","author":"J Hohmann","year":"2011","journal-title":"Phytochemistry"},{"key":"ref186","doi-asserted-by":"crossref","first-page":"9099","DOI":"10.1073\/pnas.0803601105","article-title":"Beta-caryophyllene is a dietary cannabinoid","volume":"105","author":"J Gertsch","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref187","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ajpath.2010.11.052","article-title":"Beta-caryophyllene inhibits dextran sulfate sodium-Induced colitis in mice through CB2 receptor activation and PPAR gamma pathway","volume":"178","author":"AF Bento","year":"2011","journal-title":"American Journal of Pathology"},{"key":"ref188","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.freeradbiomed.2012.01.014","article-title":"\u03b2-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner","volume":"52","author":"B Horvath","year":"2012","journal-title":"Free Radical Biology and Medicine"},{"key":"ref189","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/j.1532-2149.2012.00242.x","article-title":"Involvement of peripheral cannabinoid and opioid receptors in \u03b2-caryophyllene-induced antinociception","volume":"17","author":"S Katsuyama","year":"2013","journal-title":"European Journal of Pain"},{"key":"ref190","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0028-1088397","article-title":"In silico target fishing for rationalized ligand discovery exemplified on constituents of Ruta graveolens","volume":"75","author":"JM Rollinger","year":"2009","journal-title":"Planta Med"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jep.2007.10.023","article-title":"The effects of Morinda citrifolia L. (noni) on the immune system: its molecular mechanisms of action","volume":"115","author":"AK Palu","year":"2008","journal-title":"Journal of Ethnopharmacology"},{"key":"ref192","doi-asserted-by":"crossref","DOI":"10.1186\/1476-511X-11-8","article-title":"Effect of acute administration of Pistacia lentiscus L. essential oil on rat cerebral cortex following transient bilateral common carotid artery occlusion","volume":"11","author":"M Quartu","year":"2012","journal-title":"Lipids in Health and Disease"},{"key":"ref193","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0005-2760(97)00132-X","article-title":"Bioactive long chain N-acylethanolamines in five species of edible bivalve molluscs - Possible implications for mollusc physiology and seafood industry","volume":"1389","author":"N Sepe","year":"1998","journal-title":"Biochimica et Biophysica Acta Lipids and Lipid Metabolism"},{"key":"ref194","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0005-2760(97)00009-X","article-title":"Occurrence and metabolism of anandamide and related acyl-ethanolamides in ovaries of the sea urchin Paracentrotus lividus","volume":"1345","author":"T Bisogno","year":"1997","journal-title":"Biochimica et Biophysica Acta Lipids and Lipid Metabolism"},{"key":"ref195","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1471-4159.2005.03103.x","article-title":"Occurrence and possible biological role of the endocannabinoid system in the sea squirt Ciona intestinalis","volume":"93","author":"I Matias","year":"2005","journal-title":"Journal of Neurochemistry"},{"key":"ref196","doi-asserted-by":"crossref","first-page":"9406","DOI":"10.1073\/pnas.0914661107","article-title":"Endogenous cannabinoid signaling is essential for stress adaptation","volume":"107","author":"MN Hill","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref197","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1460-9568.2005.03916.x","article-title":"Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling","volume":"21","author":"S Patel","year":"2005","journal-title":"European Journal of Neuroscience"},{"key":"ref198","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.npp.1300601","article-title":"Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress","volume":"30","author":"MN Hill","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"ref199","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1038\/npp.2009.101","article-title":"Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at iInhibitory synapses in basolateral amygdala","volume":"34","author":"S Patel","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"ref200","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1210\/en.2010-0285","article-title":"Fast feedback inhibition of the HPA axis by glucocorticoids Is mediated by endocannabinoid signaling","volume":"151","author":"NK Evanson","year":"2010","journal-title":"Endocrinology"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbr.2009.05.013","article-title":"Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats","volume":"203","author":"CG Reich","year":"2009","journal-title":"Behavioural Brain Research"},{"key":"ref202","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.neuroscience.2010.04.007","article-title":"Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult rats","volume":"168","author":"NR Sciolino","year":"2010","journal-title":"Neuroscience"},{"key":"ref203","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/npp.2010.214","article-title":"Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation","volume":"36","author":"S Zoppi","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"ref204","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.biopsych.2006.12.001","article-title":"Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress","volume":"62","author":"M Bortolato","year":"2007","journal-title":"Biological Psychiatry"},{"key":"ref205","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuroscience.2012.11.017","article-title":"Age of stress exposure modulates the immediate and sustained effects of repeated stress on corticolimbic cannabinoid CB1 receptor binding in male rats","volume":"249","author":"TTY Lee","year":"2013","journal-title":"Neuroscience"},{"key":"ref206","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1053\/j.gastro.2010.11.003","article-title":"Corticosterone mediates reciprocal changes in CB 1 and TRPV1 receptors in primary sensory neurons in the chronically stressed rat","volume":"140","author":"SS Hong","year":"2011","journal-title":"Gastroenterology"},{"key":"ref207","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/npp.2012.36","article-title":"Genetic dissection of the role of cannabinoid type-1 receptors in the emotional consequences of repeated social stress in mice","volume":"37","author":"S Dubreucq","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"ref208","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.1523\/JNEUROSCI.5346-07.2008","article-title":"Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum","volume":"28","author":"S Rossi","year":"2008","journal-title":"Journal of Neuroscience"},{"key":"ref209","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.brainresbull.2011.04.005","article-title":"Chronic restraint stress impairs endocannabinoid mediated suppression of GABAergic signaling in the hippocampus of adult male rats","volume":"85","author":"W Hu","year":"2011","journal-title":"Brain Research Bulletin"},{"key":"ref210","doi-asserted-by":"crossref","first-page":"11188","DOI":"10.1523\/JNEUROSCI.1046-10.2010","article-title":"Repeated stress impairs endocannabinoid signaling in the paraventricular nucleus of the hypothalamus","volume":"30","author":"JI Wamsteeker","year":"2010","journal-title":"Journal of Neuroscience"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/nature03658","article-title":"An endocannabinoid mechanism for stress-induced analgesia","volume":"435","author":"AG Hohmann","year":"2005","journal-title":"Nature"},{"key":"ref212","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neulet.2005.12.008","article-title":"Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia","volume":"397","author":"K Connell","year":"2006","journal-title":"Neuroscience Letters"},{"key":"ref213","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1073\/pnas.0900835106","article-title":"Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory","volume":"106","author":"P Campolongo","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref214","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1210\/en.2006-0740","article-title":"Endocannabinoids mediate the effects of acute stress and corticosterone on sex behavior","volume":"148","author":"E Coddington","year":"2007","journal-title":"Endocrinology"},{"key":"ref215","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/0269881111409606","article-title":"Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation","volume":"26","author":"MN Wang","year":"2012","journal-title":"Journal of Psychopharmacology"},{"key":"ref216","doi-asserted-by":"crossref","first-page":"R349","DOI":"10.1152\/ajpregu.00933.2005","article-title":"Sex and hormonal cycle differences in rat brain levels of pain-related cannabimimetic lipid mediators","volume":"291","author":"HB Bradshaw","year":"2006","journal-title":"American Journal of Physiology-Regulatory Integrative and Comparative Physiology"},{"key":"ref217","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jbmt.2006.12.004","article-title":"The diagnosis of fibromyalgia in women may be influenced by menstrual cycle phase","volume":"11","author":"AJ Dunnett","year":"2007","journal-title":"Journal of Bodywork and Movement Therapies"},{"key":"ref218","first-page":"283","article-title":"Cannabimimetic effects of osteopathic manipulative treatment","volume":"105","author":"JM McPartland","year":"2005","journal-title":"Journal of the American Osteopathic Association"},{"key":"ref219","doi-asserted-by":"crossref","first-page":"14899","DOI":"10.1523\/JNEUROSCI.0114-12.2012","article-title":"Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats","volume":"32","author":"V Trezza","year":"2012","journal-title":"Journal of Neuroscience"},{"key":"ref220","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00001756-199701200-00023","article-title":"Acute administration of the CB1 cannabinoid receptor antagonist SR141716A induces anxiety-like responses in the rat","volume":"8","author":"M Navarro","year":"1997","journal-title":"Neuroreport"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s10571-011-9718-x","article-title":"Effect of acupuncture on hypothalamic-pituitary-adrenal system in maternal separation rats","volume":"31","author":"HJ Park","year":"2011","journal-title":"Cell Mol Neurobiol"},{"key":"ref222","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jpain.2008.12.012","article-title":"Endogenous anandamide and cannabinoid receptor-2 contribute to electroacupuncture analgesia in rats","volume":"10","author":"L Chen","year":"2009","journal-title":"Journal of Pain"},{"key":"ref223","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jpain.2010.02.013","article-title":"Electroacupuncture increases CB2 receptor expression on keratinocytes and infiltrating inflammatory cells in inflamed skin tissues of rats","volume":"11","author":"J Zhang","year":"2010","journal-title":"Journal of Pain"},{"key":"ref224","article-title":"Cannabinoid CB2 receptors contribute to upregulation of beta-endorphin in inflamed skin tissues by electroacupuncture","volume":"7","author":"TF Su","year":"2011","journal-title":"Molecular Pain"},{"key":"ref225","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1152\/japplphysiol.91648.2008","article-title":"Electroacupuncture modulates vlPAG release of GABA through presynaptic cannabinoid CB1 receptors","volume":"106","author":"LW Fu","year":"2009","journal-title":"J Appl Physiol"},{"key":"ref226","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1161\/STROKEAHA.110.597336","article-title":"Activation of epsilon protein kinase C-mediated anti-apoptosis is involved in rapid tolerance induced by electroacupuncture pretreatment through cannabinoid receptor type 1","volume":"42","author":"QA Wang","year":"2011","journal-title":"Stroke"},{"key":"ref227","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.neuropharm.2005.01.001","article-title":"Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: Review of the available pre-clinical data, and first human studies","volume":"48","author":"NA Darmani","year":"2005","journal-title":"Neuropharmacology"},{"key":"ref228","doi-asserted-by":"crossref","first-page":"12567","DOI":"10.1073\/pnas.1109567108","article-title":"Endocannabinoids: an appetite for fat","volume":"108","author":"V Di Marzo","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref229","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nn1457","article-title":"Endocannabinoid control of food intake and energy balance","volume":"8","author":"V Di Marzo","year":"2005","journal-title":"Nature Neuroscience"},{"key":"ref230","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/sj.ijo.0803539","article-title":"Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men","volume":"31","author":"M Cote","year":"2007","journal-title":"International Journal of Obesity"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1523\/JNEUROSCI.2648-09.2010","article-title":"Alterations in the hippocampal endocannabinoid system in diet-Induced obese mice","volume":"30","author":"F Massa","year":"2010","journal-title":"Journal of Neuroscience"},{"key":"ref232","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.2337\/diabetes.54.10.2838","article-title":"Activation of the peripheral endocannabinoid system in human obesity","volume":"54","author":"S Engeli","year":"2005","journal-title":"Diabetes"},{"key":"ref233","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/ijo.2011.8","article-title":"Investigations of the human endocannabinoid system in two subcutaneous adipose tissue depots in lean subjects and in obese subjects before and after weight loss","volume":"35","author":"MF Bennetzen","year":"2011","journal-title":"International Journal of Obesity"},{"key":"ref234","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00125-008-1178-6","article-title":"Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors","volume":"52","author":"V Di Marzo","year":"2009","journal-title":"Diabetologia"},{"key":"ref235","article-title":"Adipose tissue endocannabinoid system gene expression: depot differences and effects of diet and exercise","volume":"10","author":"TJ You","year":"2011","journal-title":"Lipids in Health and Disease"},{"key":"ref236","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042399","article-title":"Endocannabinoids measurement in human saliva as potential biomarker of obesity","volume":"7","author":"I Matias","year":"2012","journal-title":"Plos One"},{"key":"ref237","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1097\/00001756-200312020-00015","article-title":"Exercise activates the endocannabinoid system","volume":"14","author":"PB Sparling","year":"2003","journal-title":"Neuroreport"},{"key":"ref238","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.psyneuen.2011.09.017","article-title":"Intense exercise increases circulating endocannabinoid and BDNF levels in humans - possible implications for reward and depression","volume":"37","author":"E Heyman","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"ref239","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1007\/s00421-011-2237-0","article-title":"Effects of exercise stress on the endocannabinoid system in humans under field conditions","volume":"112","author":"M Feuerecker","year":"2012","journal-title":"European Journal of Applied Physiology"},{"key":"ref240","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1242\/jeb.063677","article-title":"Wired to run: exercise-induced endocannabinoid signaling in humans and cursorial mammals with implications for the \u2018runner&apos;s high\u2019","volume":"215","author":"DA Raichlen","year":"2012","journal-title":"Journal of Experimental Biology"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00421-012-2495-5","article-title":"Exercise-induced endocannabinoid signaling is modulated by intensity","volume":"113","author":"DA Raichlen","year":"2013","journal-title":"European Journal of Applied Physiology"},{"key":"ref242","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1042\/BJ20061898","article-title":"Regulation of brain anandamide by acute administration of ethanol","volume":"404","author":"B Ferrer","year":"2007","journal-title":"Biochemical Journal"},{"key":"ref243","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1471-4159.2008.05685.x","article-title":"Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons","volume":"107","author":"BS Basavarajappa","year":"2008","journal-title":"Journal of Neurochemistry"},{"key":"ref244","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00213-005-0195-0","article-title":"Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo","volume":"183","author":"S Perra","year":"2005","journal-title":"Psychopharmacology"},{"key":"ref245","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1530-0277.2007.00588.x","article-title":"Alcohol inhibits spontaneous activity of basolateral amygdala projection neurons in the rat: involvement of the endocannabinoid system","volume":"32","author":"S Perra","year":"2008","journal-title":"Alcoholism-Clinical and Experimental Research"},{"key":"ref246","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1111\/j.1460-9568.2007.05606.x","article-title":"Ethanol reverses the direction of long-term synaptic plasticity in the dorsomedial striatum","volume":"25","author":"HH Yin","year":"2007","journal-title":"Eur J Neurosci"},{"key":"ref247","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.neuropharm.2009.12.006","article-title":"Acute ethanol treatment prevents endocannabinoid-mediated long-lasting disinhibition of striatal output","volume":"58","author":"RBC Clarke","year":"2010","journal-title":"Neuropharmacology"},{"key":"ref248","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0006-8993(98)00175-9","article-title":"Chronic ethanol administration down-regulates cannabinoid receptors in mouse brain synaptic plasma membrane","volume":"793","author":"BS Basavarajappa","year":"1998","journal-title":"Brain Res"},{"key":"ref249","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0006-8993(98)01072-5","article-title":"Down-regulation of cannabinoid receptor agonist-stimulated [35S]GTP gamma S binding in synaptic plasma membrane from chronic ethanol exposed mouse","volume":"815","author":"BS Basavarajappa","year":"1999","journal-title":"Brain Res"},{"key":"ref250","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/alcalc\/agh036","article-title":"Chronic ethanol consumption regulates cannabinoid CB1 receptor gene expression in selected regions of rat brain","volume":"39","author":"S Ortiz","year":"2004","journal-title":"Alcohol Alcohol"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1369-1600.2010.00299.x","article-title":"Innate difference in the endocannabinoid signaling and its modulation by alcohol consumption in alcohol-preferring sP rats","volume":"17","author":"KY Vinod","year":"2012","journal-title":"Addiction Biology"},{"key":"ref252","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.neuint.2006.05.002","article-title":"Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system","volume":"49","author":"KY Vinod","year":"2006","journal-title":"Neurochemistry International"},{"key":"ref253","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1096\/fj.01-0593com","article-title":"Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol","volume":"16","author":"R Rimondini","year":"2002","journal-title":"Faseb Journal"},{"key":"ref254","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1530-0277.2007.00366.x","article-title":"Bidirectional alterations of hippocampal cannabinoid 1 receptors and their endogenous ligands in a rat model of alcohol withdrawal and dependence","volume":"31","author":"S Mitrirattanakul","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"key":"ref255","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.neuropharm.2011.01.014","article-title":"Intermittent ethanol consumption depresses endocannabinoid-signaling in the dorsolateral striatum of rat","volume":"61","author":"L Adermark","year":"2011","journal-title":"Neuropharmacology"},{"key":"ref256","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/alcalc\/agr162","article-title":"Effect of an acute consumption of a moderate amount of ethanol on plasma endocannabinoid levels in humans","volume":"47","author":"M Feuerecker","year":"2012","journal-title":"Alcohol and Alcoholism"},{"key":"ref257","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jpsychires.2009.11.013","article-title":"Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides","volume":"44","author":"KY Vinod","year":"2010","journal-title":"Journal of Psychiatric Research"},{"key":"ref258","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0006-8993(02)03344-9","article-title":"Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine","volume":"954","author":"S Gonzalez","year":"2002","journal-title":"Brain Research"},{"key":"ref259","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.drugalcdep.2005.01.008","article-title":"Transdermal nicotine alters some of marihuana&apos;s effects in male and female volunteers","volume":"79","author":"DM Penetar","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"ref260","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s00213-005-0251-9","article-title":"Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice","volume":"184","author":"GN Balerio","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01.fbp.0000197460.16516.81","article-title":"Nicotine pre-exposure does not potentiate the locomotor or rewarding effects of Delta-9-tetrahydrocannabinol in rats","volume":"17","author":"B Le Foll","year":"2006","journal-title":"Behav Pharmacol"},{"key":"ref262","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0091-3057(78)90320-9","article-title":"Interactions of delta9-tetrahydrocannabinol with d-amphetamine, cocaine, and nicotine in rats","volume":"8","author":"GT Pryor","year":"1978","journal-title":"Pharmacol Biochem Behav"},{"key":"ref263","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1124\/jpet.106.116830","article-title":"Nicotinic facilitation of delta-9-tetrahydrocannabinol discrimination involves endogenous anandamide","volume":"321","author":"M Solinas","year":"2007","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref264","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/sj.bjp.0704479","article-title":"Behavioural and biochemical evidence for interactions between \u0394<sup>9<\/sup>-tetrahydrocannabinol and nicotine","volume":"135","author":"E Valjent","year":"2002","journal-title":"British Journal of Pharmacology"},{"key":"ref265","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/FBP.0b013e3282f00c10","article-title":"Influence of nicotinic receptor modulators on CB2 cannabinoid receptor agonist (JWH133)-induced antinociception in mice","volume":"18","author":"MR Jafari","year":"2007","journal-title":"Behav Pharmacol"},{"key":"ref266","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028142","article-title":"Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect ofFAAH inhibition","volume":"6","author":"A Cippitelli","year":"2011","journal-title":"PLoS ONE"},{"key":"ref267","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.brainres.2006.07.075","article-title":"Mouse cerebellar nicotinic-cholinergic receptor modulation of \u0394<sup>9<\/sup>-THC ataxia: role of the \u03b1<sub>4<\/sub>\u03b2<sub>2<\/sub> subtype","volume":"1115","author":"AD Smith","year":"2006","journal-title":"Brain Research"},{"key":"ref268","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/npp.2012.210","article-title":"The volitional nature of nicotine exposure alters anandamide and oleoylethanolamide levels in the ventral tegmental area","volume":"38","author":"MW Buczynski","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"ref269","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbr.2006.04.012","article-title":"Adolescent exposure to nicotine modifies acute functional responses to cannabinoid agonists in rats","volume":"172","author":"EM Marco","year":"2006","journal-title":"Behav Brain Res"},{"key":"ref270","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijdevneu.2008.12.008","article-title":"Chronic nicotine alters cannabinoid-mediated locomotor activity and receptor density in periadolescent but not adult male rats","volume":"27","author":"LL Werling","year":"2009","journal-title":"International Journal of Developmental Neuroscience"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bbr.2010.01.004","article-title":"WIN55,212-2 induced deficits in spatial learning are mediated by cholinergic hypofunction","volume":"208","author":"L Robinson","year":"2010","journal-title":"Behavioural Brain Research"},{"key":"ref272","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM185704160561101","article-title":"On the haschisch or Cannabis indica","volume":"56","author":"J Bell","year":"1857","journal-title":"Boston Medical and Surgical Journal"},{"key":"ref273","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1523\/JNEUROSCI.4920-09.2010","article-title":"Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A<sub>1<\/sub> receptors","volume":"30","author":"AF Hoffman","year":"2010","journal-title":"Journal of Neuroscience"},{"key":"ref274","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1124\/mol.104.000604","article-title":"Long-term administration of Delta9-tetrahydrocannabinol desensitizes CB1-, adenosine A1-, and GABAB-mediated inhibition of adenylyl cyclase in mouse cerebellum","volume":"66","author":"DE Selley","year":"2004","journal-title":"Mol Pharmacol"},{"key":"ref275","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0003-9993(97)90011-3","article-title":"Caffeine and chronic back pain","volume":"78","author":"JM McPartland","year":"1997","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"key":"ref276","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00634153","article-title":"EEG and behavioral effects of delta9-tetrahydrocannabinol in combination with stimulant drugs in rabbits","volume":"50","author":"P Consroe","year":"1976","journal-title":"Psychopharmacology (Berl)"},{"key":"ref277","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.neuropharm.2008.10.013","article-title":"Caffeine drinking potentiates cannabinoid transmission in the striatum: Interaction with stress effects","volume":"56","author":"S Rossi","year":"2009","journal-title":"Neuropharmacology"},{"key":"ref278","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/npp.2010.179","article-title":"Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A<sub>1<\/sub> receptors and chronic caffeine administration: Implications for the effects of \u0394<sup>9<\/sup>-tetrahydrocannabinol on spatial memory","volume":"36","author":"VC Sousa","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"ref279","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(98)00649-9","article-title":"Endocannabinoids","volume":"359","author":"R Mechoulam","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"ref280","unstructured":"McPartland JM, Guy GW (2004) The evolution of Cannabis and coevolution with the cannabinoid receptor\u2014a hypothesis. In: Guy GW, Robson R, Strong K, Whittle B, editors. The Medicinal Use of Cannabis. London: Royal Society of Pharmacists. pp. 71\u2013102."},{"key":"ref281","first-page":"A228","article-title":"Opioid and cannabinoid receptor protein levels following chronic treatment","volume":"15","author":"DL Cichewicz","year":"2001","journal-title":"FASEB Journal"},{"key":"ref282","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0091-3057(95)00023-P","article-title":"Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta-9-tetrahydrocannabinol","volume":"51","author":"J Romero","year":"1995","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"ref283","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0169-328X(98)00232-0","article-title":"Effects of long-term exposure to delta9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions","volume":"62","author":"S Zhuang","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"key":"ref284","doi-asserted-by":"crossref","first-page":"8057","DOI":"10.1523\/JNEUROSCI.16-24-08057.1996","article-title":"Effects of chronic treatment with \u0394<sup>9<\/sup>-tetrahydrocannabinol on cannabinoid-stimulated [<sup>35<\/sup>S]GTP\u03b3S autoradiography in rat brain","volume":"16","author":"LJ Sim","year":"1996","journal-title":"Journal of Neuroscience"},{"key":"ref285","doi-asserted-by":"crossref","first-page":"p855","DOI":"10.1016\/0006-2952(94)00538-W","article-title":"Stimulation of anandamide biosynthesis in N-18TG2 neuroblastoma cells by delta-9-tetrahydrocannabinol (THC)","volume":"49","author":"SH Burstein","year":"1995","journal-title":"Biochemical Pharmacology"},{"key":"ref286","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1046\/j.1471-4159.1999.0732447.x","article-title":"Chronic \u0394<sup>9<\/sup>-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain","volume":"73","author":"CS Breivogel","year":"1999","journal-title":"Journal of Neurochemistry"},{"key":"ref287","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/npp.2010.44","article-title":"FAAH<sup>\u2212\/\u2212<\/sup> mice display differential tolerance, dependence, and cannabinoid receptor adaptation after \u0394<sup>9<\/sup>-tetrahydrocannabinol and anandamide administration","volume":"35","author":"KW Falenski","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref288","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1046\/j.1471-4159.2000.0741627.x","article-title":"Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of D<sup>9<\/sup>-tetrahydrocannabinol-tolerant rats","volume":"74","author":"V Di Marzo","year":"2000","journal-title":"Journal of Neurochemistry"},{"key":"ref289","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.neuroscience.2006.11.012","article-title":"Chronic use of marijuana decreases cannabinoid receptor binding and mRNA expression in the human brain","volume":"145","author":"J Villares","year":"2007","journal-title":"Neuroscience"},{"key":"ref290","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/mp.2011.82","article-title":"Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers","volume":"17","author":"J Hirvonen","year":"2012","journal-title":"Molecular Psychiatry"},{"key":"ref291","article-title":"Blunted Psychotomimetic and Amnestic Effects of Delta-9-Tetrahydrocannabinol in Frequent Users of Cannabis","author":"DC D'Souza","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"ref292","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000338642","article-title":"CB1 and CB2 receptor expression and promoter methylation in patients with cannabis dependence","volume":"19","author":"A Rotter","year":"2013","journal-title":"European Addiction Research"},{"key":"ref293","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.neuropharm.2005.07.012","article-title":"\u0394<sup>9<\/sup>-Tetrahydrocannabinol-induced desensitization of cannabinoid-mediated inhibition of synaptic transmission between hippocampal neurons in culture","volume":"49","author":"DJ Lundberg","year":"2005","journal-title":"Neuropharmacology"},{"key":"ref294","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1471-4159.1999.0730493.x","article-title":"Internalization and recycling of the CB1 cannabinoid receptor","volume":"73","author":"C Hsieh","year":"1999","journal-title":"J Neurochem"},{"key":"ref295","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0022-3565(25)24023-X","article-title":"Development of cross-tolerance between delta-9-tetrahydrocannabinol, CP 55,940 and WIN 55,212","volume":"271","author":"F Fan","year":"1994","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref296","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/sj.bjp.0705792","article-title":"Identification of a potent and highly efficacious, yet slowly desensitizing CB1 cannabinoid receptor agonist","volume":"142","author":"T Luk","year":"2004","journal-title":"British Journal of Pharmacology"},{"key":"ref297","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1124\/jpet.102.035618","article-title":"Effect of chronic administration of <italic>R<\/italic>-(+)-[2,3-dihydro-5- methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-<italic>de<\/italic>]-1,4- benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or \u0394<sup>9<\/sup>-tetrahydrocannabinol on cannabinoid receptor adaptation in mice","volume":"303","author":"LJ Sim-Selley","year":"2002","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref298","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuropharm.2010.04.013","article-title":"\u0394<sup>9<\/sup>-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus","volume":"59","author":"N Laaris","year":"2010","journal-title":"Neuropharmacology"},{"key":"ref299","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1124\/mol.55.1.8","article-title":"\u0394<sup>9<\/sup>-Tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture","volume":"55","author":"M Shen","year":"1999","journal-title":"Molecular Pharmacology"},{"key":"ref300","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1113\/jphysiol.2005.091918","article-title":"Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones","volume":"569","author":"A Straiker","year":"2005","journal-title":"Journal of Physiology-London"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0026-895X(24)26516-0","article-title":"Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide","volume":"57","author":"W Gonsiorek","year":"2000","journal-title":"Molecular Pharmacology"},{"key":"ref302","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.bjp.0704297","article-title":"Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB<sub>1<\/sub> receptor-dependent G-protein activation in rat cerebellar membranes","volume":"134","author":"JR Savinainen","year":"2001","journal-title":"British Journal of Pharmacology"},{"key":"ref303","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/42015","article-title":"A second endogenous cannabinoid that modulates long-term potentiation","volume":"388","author":"N Stella","year":"1997","journal-title":"Nature"},{"key":"ref304","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1124\/jpet.300.1.34","article-title":"The potent emetogenic effects of the endocannabinoid, 2-AG (2- arachidonoylglycerol) are blocked by \u0394<sup>9<\/sup>-tetrahydrocannabinol and other cannnabinoids","volume":"300","author":"NA Darmani","year":"2002","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref305","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nn1251","article-title":"A single in-vivo exposure to delta 9THC blocks endocannabinoid-mediated synaptic plasticity","volume":"7","author":"S Mato","year":"2004","journal-title":"Nat Neurosci"},{"key":"ref306","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.neuropharm.2003.11.005","article-title":"\u0394<sup>9<\/sup>-Tetrahydrocannabinol antagonizes endocannabinoid modulation of synaptic transmission between hippocampal neurons in culture","volume":"46","author":"BG Kelley","year":"2004","journal-title":"Neuropharmacology"},{"key":"ref307","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1124\/mol.108.051482","article-title":"Modulation of excitatory synaptic transmission by \u0394<sup>9<\/sup>-tetrahydrocannabinol switches from agonist to antagonist depending on firing rate","volume":"75","author":"AM Roloff","year":"2009","journal-title":"Molecular Pharmacology"},{"key":"ref308","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0014-2999(97)01255-7","article-title":"Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain","volume":"336","author":"TH Burkey","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"ref309","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0022-3565(24)37833-4","article-title":"Anandamide, an endogenous cannabinoid, has a very low physical dependence potential","volume":"287","author":"MD Aceto","year":"1998","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref310","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-8993(95)00790-W","article-title":"Anandamides: tolerance and cross-tolerance to delta-9-tetrahydrocannabinol","volume":"697","author":"E Fride","year":"1995","journal-title":"Brain Research"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0022-3565(24)37876-0","article-title":"Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses","volume":"287","author":"DW Bonhaus","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"ref312","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1124\/mol.56.6.1362","article-title":"Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors","volume":"56","author":"M Glass","year":"1999","journal-title":"Mol Pharmacol"},{"key":"ref313","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0022-3565(25)24465-2","article-title":"Low doses of anandamides inhibit pharmacological effects of delta-9-tetrahydrocannabinol","volume":"272","author":"E Fride","year":"1995","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref314","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/j.1476-5381.1993.tb13989.x","article-title":"Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide","volume":"110","author":"RG Pertwee","year":"1993","journal-title":"British Journal of Pharmacology"},{"key":"ref315","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.neuropharm.2011.10.011","article-title":"Enhancement of the behavioral effects of endogenous and exogenous cannabinoid agonists by phenylmethyl sulfonyl fluoride","volume":"62","author":"RE Vann","year":"2012","journal-title":"Neuropharmacology"},{"key":"ref316","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neuropharm.2007.07.006","article-title":"Cross-sensitization and cross-tolerance between exogenous cannabinoid antinociception and endocannabinoid-mediated stress-induced analgesia","volume":"54","author":"RL Suplita","year":"2008","journal-title":"Neuropharmacology"},{"key":"ref317","doi-asserted-by":"crossref","first-page":"20270","DOI":"10.1073\/pnas.0909411106","article-title":"Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo","volume":"106","author":"JZ Long","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref318","first-page":"57","article-title":"Side effects of pharmaceuticals not elicited by comparable herbal medicines: the case of tetrahydrocannabinol and marijuana","volume":"5","author":"JM McPartland","year":"1999","journal-title":"Alternative Therapies in Health and Medicine"},{"key":"ref319","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1300\/J175v01n03_08","article-title":"Cannabis and cannabis extracts: Greater than the sum of their parts","volume":"1","author":"JM McPartland","year":"2001","journal-title":"Journal of Cannabis Therapeutics"},{"key":"ref320","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.brainres.2007.09.090","article-title":"Cannabidiol potentiates pharmacological effects of \u0394<sup>9<\/sup>-tetrahydrocannabinol via CB1 receptor-dependent mechanism","volume":"1188","author":"K Hayakawa","year":"2008","journal-title":"Brain Research"},{"key":"ref321","article-title":"Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis","volume":"8","author":"SA Wolf","year":"2010","journal-title":"Cell Communication and Signaling"},{"key":"ref322","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"T Bisogno","year":"2001","journal-title":"British Journal of Pharmacology"},{"key":"ref323","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid-enriched <italic>Cannabis<\/italic> extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"L De Petrocellis","year":"2011","journal-title":"British Journal of Pharmacology"},{"key":"ref324","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/nn.2616","article-title":"Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system","volume":"13","author":"JE Schlosburg","year":"2010","journal-title":"Nature Neuroscience"},{"key":"ref325","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0952-3278(03)00056-5","article-title":"n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice","volume":"69","author":"S Watanabe","year":"2003","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref326","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbalip.2007.11.001","article-title":"Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes","volume":"1781","author":"I Matias","year":"2008","journal-title":"Biochimica Et Biophysica Acta-Molecular and Cell Biology of Lipids"},{"key":"ref327","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbalip.2008.01.006","article-title":"Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine","volume":"1781","author":"A Artmann","year":"2008","journal-title":"Biochimica Et Biophysica Acta-Molecular and Cell Biology of Lipids"},{"key":"ref328","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.bjp.0704767","article-title":"Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol","volume":"136","author":"TC Kirkham","year":"2002","journal-title":"British Journal of Pharmacology"},{"key":"ref329","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0006-8993(03)03046-4","article-title":"Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain","volume":"983","author":"L Hanus","year":"2003","journal-title":"Brain Research"},{"key":"ref330","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/WNR.0b013e32832a0a5f","article-title":"Goldfish CB1 mRNA expression is affected by fasting and anandamide administration","volume":"20","author":"E Cottone","year":"2009","journal-title":"Neuroreport"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1471-4159.2005.03406.x","article-title":"The endocannabinoid system in the brain of Carassius auratus and its possible role in the control of food intake","volume":"95","author":"M Valenti","year":"2005","journal-title":"Journal of Neurochemistry"},{"key":"ref332","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/SLA.0b013e318166fd5f","article-title":"Sustained weight loss after roux-en-y gastric bypass is characterized by down regulation of endocannabinoids and mitochondrial function","volume":"247","author":"A Guijarro","year":"2008","journal-title":"Annals of Surgery"},{"key":"ref333","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neulet.2009.07.011","article-title":"The effect of leptin receptor deficiency and fasting on cannabinoid receptor 1 mRNA expression in the rat hypothalamus, brainstem and nodose ganglion","volume":"463","author":"J Jelsing","year":"2009","journal-title":"Neuroscience Letters"},{"key":"ref334","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.bbrc.2006.12.213","article-title":"Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-delta","volume":"354","author":"ZC Yan","year":"2007","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"ref335","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nbd.2009.06.013","article-title":"Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis","volume":"36","author":"S Rossi","year":"2009","journal-title":"Neurobiology of Disease"},{"key":"ref336","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/npp.2009.141","article-title":"Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum","volume":"35","author":"V De Chiara","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref337","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.neuint.2010.07.001","article-title":"Physical exercise in adolescence changes CB1 cannabinoid receptor expression in the rat brain","volume":"57","author":"SG da Silva","year":"2010","journal-title":"Neurochemistry International"},{"key":"ref338","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/hipo.20647","article-title":"Endogenous cannabinoid signaling is required for voluntary exercise-induced enhancement of progenitor cell proliferation in the hippocampus","volume":"20","author":"MN Hill","year":"2010","journal-title":"Hippocampus"},{"key":"ref339","doi-asserted-by":"crossref","first-page":"181687","DOI":"10.1155\/2012\/181687","article-title":"Effects of exercise training on molecular markers of lipogenesis and lipid partitioning in fructose-induced liver fat accumulation","volume":"2012","author":"S Yasari","year":"2012","journal-title":"J Nutr Metab"},{"key":"ref340","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1471-4159.1999.0720522.x","article-title":"Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells","volume":"72","author":"BS Basavarajappa","year":"1999","journal-title":"Journal of Neurochemistry"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0925-4439(00)00085-5","article-title":"Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons","volume":"1535","author":"BS Basavarajappa","year":"2000","journal-title":"Biochimica Et Biophysica Acta-Molecular Basis of Disease"},{"key":"ref342","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0014-2999(03)01557-7","article-title":"Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons","volume":"466","author":"BS Basavarajappa","year":"2003","journal-title":"European Journal of Pharmacology"},{"key":"ref343","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/S0014-2999(97)00146-5","article-title":"delta 9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain","volume":"323","author":"TH Burkey","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"ref344","doi-asserted-by":"crossref","first-page":"PL1","DOI":"10.1016\/S0024-3205(98)00238-0","article-title":"Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of \u0394<sup>9<\/sup>-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors","volume":"63","author":"F Petitet","year":"1998","journal-title":"Life Sciences"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0089566","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T01:45:17Z","timestamp":1746150317000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0089566"}},"subtitle":[],"editor":[{"given":"Andrej A.","family":"Romanovsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,12]]},"references-count":344,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0089566","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,12]]}}}